Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-11-13
1991-05-28
Doll, John
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 92, A61K 3900, A61K 39002, A61K 3902, A61K 3912
Patent
active
050193848
ABSTRACT:
Novel methods or compositions are provided for modulating the immune system, so as to be able to selectively stimulate or inactivate lymphocytes in relation to a particular transplantation antigen content. Particularly, mixtures may be employed associated with the more common transplanatation antigens of a host population. In this manner, a large number of people can be treated, for example, by immunization, stimulation of particular T-cells or B-cells in relation to a pathogenic invasion of other aberrant state, e.g. neoplasia, treatment of autoimmune diseases, and the like. Particularly, the compositions may involve an oligopeptide involving as a first region a consensus sequence and an epitope or the first region may be joined to a second region comprising an antibody target sequence which is capable of competing with an epitopic site of an antigen of interest.
REFERENCES:
patent: 4285930 (1981-08-01), Likhite
patent: 4469677 (1984-09-01), Michael et al.
patent: 4473555 (1984-09-01), Nestor et al.
patent: 4478823 (1984-10-01), Sanderson
patent: 4565696 (1986-01-01), Heath et al.
patent: 4599230 (1986-07-01), Milich et al.
patent: 4683136 (1987-07-01), Milich et al.
patent: 4707357 (1987-11-01), Dame et al.
patent: 4722840 (1988-02-01), Valenzuela et al.
T-Lymphocyte Recognition of Antigen in Association with Gene Products of the Major Histocompatability Complex, Schwartz, Ann. Rev. Immunol. (1985) 3:237-261.
Structural Feature of Protein Antigenic Sites Recognized by Helper T Cells: What Makes a Site Immunodominant, Berzofsky, The Year in Immunology (1986) 2: 28-38.
Ia Molecule-Associated Selectivity in T Cell Recognition of a 23 Amino Acid Peptide of Lysozyme, Shastri et al., J Exp. Med. (1986) 164:882-896.
Distinct Recognition Phenotypes Exist for T-Cell Clones Specific for Small Peptide Regions of Proteins, Shastri et al., J. Exp. Med. (1985) 162:332-345.
The Basis for the Immunoregulatory Role of Macrophages and Other Accessory Cells, Unanue and Allen, Science, (1987) 236:551-557.
Interaction of Peptide Antigens and Class II Major Histocompatability Complex Antigen, Guillet et al., Nature (1986) 324:260-262.
T-Cell Antigenic Sites Tend To Be Amphipathic Structures, DeLisi and Berzofsky, Proc. Natl. Acad. Sci. USA (1985) 82:7048-7052.
The Epitopes of Influenza Nucleoprotein Recognized by Cytotoxic T-Lymphocytes Can Be Defined With Short, Synthetic Peptides, Townsend et al., Cell (1986) 44:959-968.
T-Cell Activation by Peptide Antigen: Effect of Peptide Sequence and Method of Antigen Presentation, Watts et al., Proc. Natl. Acad. Sci. USA (1985) 82:5480-5484.
The T Lymphocyte Response to Cytochrome C, Schwartz et al., J. Immun. (1985) 135:2598-2608.
Binding of Immunogenic Peptides to Ia Histocompatability Molecules, Babbitt et al., Nature (1985) 317:359-361.
Neonatal T-Cell Tolerance to Minimal Immunogenic Peptides is Caused by Clonal Inactivation, Gammon et al., Nature (1986) 319:413-415.
Antigenic Competition at the Level of Peptide-Ia Binding, Babbitt et al., Proc. Natl. Acad. Sci. USA (1986) 83:4509-4513.
T-Cell Mediated Association of Peptide Antigen and Major Histocompatability Complex Protein Detected by Energy Transfer in an Evanescent Wave-Field, Watts et al., Nature (1986) 320:179-181.
T-Cell Repertoire for Recognition of a Phylogenetically Distinct Protein Antigen, Finnegan et al., J. Exp. Med. (1986) 164:897-910.
I-A-Restricted T-Cell Antigen Recognition, Lechler et al., J. Exp. Med. (1986) 163:678-696.
T-Cell Recognition of Antigen and the Ia Molecule as a Ternary Complex, Ashwell and Schwartz, Nature (1986) 320:176-179.
Antigen Recognition by H-2-Restricted T-Cells, Shimonkevitz et al., J. Immunol. (1984) 133:2067-2074.
Molecular Mapping of a Histocompatability-Restricted Immunodominant T-Cell Epitope with Synthetic and Natural Peptides: Implications for T-Cell Antigenic Structure, Berkower et al., J. Immunol. (1986) 136:2498-2503.
Chemically Related Antigens Compete for Presentation by Accessory Cells to T-Cells, Werdelin, J. Immunol. (1982) 129:1883-1891.
Inhibition of Antigen Specific T Lympocyte Activation by Structurally Related Ir Gene-Controlled Polymer, Rock and Benacerraf, J. Exp. Med. (1983) 157:1618-1634.
Inhibition of Antigen Specific T Lympocyte Activation by Structurally Related Ir Gene-Controlled Polymer, Rock and Benacerraf, J. Exp. Med. (1984) 160:1864-1879.
Analogs that Compete for Antigen Binding to an Arsonate-Reactive T-Cell Clone Inhibit the Functional Response to Arsonate, Rao et al., Cell (1984) 36:889-895.
Identification of Distinct Predominant Epitopes Recognized by Myoglobin-Specific T-Cells under the Control of Different Ir Genes and Characterization of Representative T-Cell Clones, Berkower et al., J. Immunol. (1984) 132:1370-1378.
High Frequency and Non-random Distribution of Alloreactivity in T-Cell Clones Selected for Recognition of Foreign Antigen in Association with Self Class II Molecules, Ashwell et al., J. Immunol. (1986) 136:389-395.
Isolation and Characterization of a cDNA Clone with a Murine I-E.sub..beta. Polypeptide Chain, Mengle-Gaw and McDevitt, Proc. Natl. Acad. Sci. USA (1983) 80:7621-7625.
Murine I-A.sub..beta. Chain Polymorphism: Nucleotide Sequences of Three Allelic I-A.sub..beta. Genes, Choi et al., Science (1983) 222:283-286.
Peptides Related to the Antigenic Determinant Block T-Cell Recognition of the Native Protein as Processed by Antigen Presenting Cells, Lakey et al., Eur. J. Immunol. (1986) 16:721-727.
Histocompatability Restrictions Explained, Marx, Science (1987) 235:843-844.
Amphiphilic Secondary Structure: Design of Peptide Hormones, Kaiser and Kezdy, Science (1984) 223:249-254.
Efficacy of Murine Malaria Sporozoite Vaccine: Implications for Human Vaccine Development, Egan et al., Science (1987) 236:453-456.
A Synthetic Decapeptide of Influenza Virus Hemagglutinin Elicits Helper T-Cells with the Same Fine Recognition Specificities as Occur in Response to Whole Virus, Hackett et al., J. Immunol. (1985) 135:1391-1394.
The Somatic Generation of Immune Recognition, Jerne, Eur. J. Immunol. (1971) 1:1-9.
Solids Phase Peptides Synthesis, I, The Synthesis of a Tetrapeptide, Merrifield, J. Am. Chem. Soc. (1963) 85:2149-2154.
Non-overlapping T and B Cell Determinants on a Hepatitis B Surface Antigen Pre-S(2) Lesion Synthesis Peptide, Milich et al., J. Exp. Med. (1986) 164:532-547.
Primary Structure of .lambda. Repressor, Sauer and Anderegg, Biochemistry (1978) 17:1092-1100.
Identification of the Determinant Recognized by Two T-Cell Hybridomas, Allen et al., Proc. Natl. Acad. Sci. USA (1984) 81:2489-2493.
Use of Synthetic Peptides of Influenza Nucleoprotein to Define Epitopes Recongized by Class I Restricted Cytotoxic T Lymphocytes, Bastin et al., J. Exp. Med. (1987) 165:1508-1523.
A Possible Immunodominant Epitope Recognized by Murine T Lymphocytes Immune to Different Myoglobins, Berkower et al., Proc. Natl. Acad. Sci. USA (1982) 79:4723-4727.
The Relation between Major Histocompatability Complex (MHC) Restriction in the Capacity of Ia to Bind Immunogenic Peptides, Buus et al., Science (1987) 235:1353-1358.
The Ia Molecule of the Antigen-presenting Cell plays a Critical Role in Immune Response Gene Regulation of T-Cell Activation, Heber-Katz-et al., J. Mol. Cell. Immunol. (1983) 1:3-14.
Absence of Ir Gene of T-Cells Recognizing a Foreign Antigen in the Context of Allogeneic MHC Molecules, Ishii et al., Nature (1982) 295:531-533.
HLA-DQ is Epistatic to HLA-DR in Controlling the Immune Response to Schistosomal Antigen in Humans, Hirayama et al., Nature, (1987) 327:426-430.
Inhibition of Alloreactive Cytotoxic T Lymphocytes by Peptides from the .alpha..sub.a Domain of HLA-A2, Parnham et al., Nature (1987) 235;14 625-628.
Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite Protein, Good et al., Science (1987) 235:1059-1062.
Allele-Specific Control of Ia Molecule Surface Expression and Confirmation: Implications for a General Model of Ia Structure-function Relationships, Braunstein and Germain, Proc. Natl. Acad. Sci. USA, (1987) 84:2921-2925.
Guillet et al., Chem. Abstr., v
Gefter Malcolm L.
Guillet Jean G.
Chan Christina
Doll John
Massachusetts Institute of Technology
Rowland Bertram I.
LandOfFree
Immunonodulating compositions and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunonodulating compositions and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunonodulating compositions and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-35083